ALB vs INFU · rev $1.74B vs P/E 25, rev $70.6M
Albemarle Corp (ALB) versus InfuSystems Holdings Inc (INFU) — a side-by-side from cached financials, not a winner call.
Albemarle Corp (ALB) is a specialty chemicals company listed on US.
InfuSystems Holdings Inc (INFU) is a medical devices company listed on US.
Latest reported ALB revenue for 2026-06-30 was $1.74B. Net income was $480.0M. Revenue was up 22.0% from 2026-03-31 to 2026-06-30. ALB currently screens at market cap $8.00B.
Latest reported INFU revenue for 2026-06-30 was $70.6M. Net income was $4.2M. INFU currently screens at market cap $186.5M and trailing P/E 25.0.
ALB currently screens at market cap $8.00B. INFU currently screens at market cap $186.5M and trailing P/E 25.0.
Not investment advice. Open the ALB and INFU stock pages for the full models.
Not investment advice.